Atrial fibrillation in transthyretin amyloid cardiomyopathy: marker of disease severity and implications for multidomain reassessment
- DOI
- 10.1007/s10741-026-10679-3
- Published
- 2026-09-14
- Container
- Heart Failure Reviews
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s10741-026-10679-3,
title = {Atrial fibrillation in transthyretin amyloid cardiomyopathy: marker of disease severity and implications for multidomain reassessment},
author = {Carlos M. Peñate and Orlando Henriquez Italin and Andrew S. Dzebu and Kevin M. Alexander},
year = {2026},
journal = {Heart Failure Reviews},
doi = {10.1007/s10741-026-10679-3},
url = {https://doi.org/10.1007/s10741-026-10679-3}
}RIS
TY - JOUR TI - Atrial fibrillation in transthyretin amyloid cardiomyopathy: marker of disease severity and implications for multidomain reassessment AU - Carlos M. Peñate AU - Orlando Henriquez Italin AU - Andrew S. Dzebu AU - Kevin M. Alexander PY - 2026 JO - Heart Failure Reviews DO - 10.1007/s10741-026-10679-3 UR - https://doi.org/10.1007/s10741-026-10679-3 ER -
APA
Peñate, C. M., Italin, O. H., Dzebu, A. S., & Alexander, K. M. (2026). Atrial fibrillation in transthyretin amyloid cardiomyopathy: marker of disease severity and implications for multidomain reassessment. Heart Failure Reviews. https://doi.org/10.1007/s10741-026-10679-3
Source records
- crossref · retrieved 2026-09-25T05:01:18.576Z